CMS has proposed to begin a Medicare value-based purchasing program in 2013, two years earlier than the reform law requires, according to an American Medical News report. Under President Obama’s ...

Editor’s note: This article by Tony Mira, president and CEO of Anesthesia Business Consultants, an anesthesia & pain management billing and practice management services company, originally appeared in ...

The U.S. may have introduced the Hospital Value-Based Purchasing program to incentivize higher quality care, but a new study published in BMJ suggests the program has had little effect on 30-day ...

More than 1,800 hospitals will see payments from the federal government rise in 2016 due to improvements in quality under the Centers for Medicare and Medicaid Services value-based purchasing program, ...

A Medicare hospital quality improvement program has failed to yield reduced mortality for patients with acute myocardial infarction or heart failure 4 years into the program, a new study has found.

While some nursing homes have earned incentive pay for reducing their hospital readmissions, the decade-old program that pays for those bonuses has not led to any widespread improvements, a ...

RICHMOND, Va — Why is Virginia's Medicaid agency awarding the state's lowest quality nursing homes millions of dollars in bonus payments that are meant to reward quality? That's the question some ...

Medicare’s upcoming health equity adjustment in the Hospital Value-Based Purchasing (HVBP) program will reduce disproportionate penalization among safety net hospitals and those serving high ...

Health Affairs' Rob Lott interviews Robert Burke of the University of Pennsylvania about his recent paper which evaluates outcomes for skilled nursing facilities value-based purchasing programs. Order ...

The Ambulatory Surgery Center Association (ASCA) has commended HHS Secretary Kathleen Sebelius and HHS for its framework to establish a Medicare value-based purchasing (VBP) program for ambulatory ...

Health may be priceless, but healthcare is not. With medical costs on the rise, insurance companies and government payers are increasingly asking pharmaceutical companies and device manufacturers to ...